InsidersTradesSigma
Browse the detailed record of transactions filed by 전교중, Président. Insider active across 2 companies, notably 지투지바이오. Aggregated, 3 disclosures have been logged. Activity tracked since 27 March 2026. The latest transaction was filed on 27 March 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Jeon Kyo-jung is the Chairman of G2G Bio, a company specializing in biotechnology. In this role, he oversees strategic direction and the development of new products. G2G Bio is recognized for its innovations in the biotechnology field.